Ken Griffin’s BIO-key International BKYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,164
Closed -$17.1K 13008
2025
Q4
$17.1K Buy
3,164
+590
+23% +$4.51K ﹤0.01% 12374
2025
Q3
$18.5K Buy
+2,574
New +$20.1K ﹤0.01% 12503
2025
Q1
Sell
-2,033
Closed -$34.8K 14500
2024
Q4
$34.8K Buy
+2,033
New +$19.8K ﹤0.01% 12738
2023
Q4
Sell
-119
Closed -$11.1K 14291
2023
Q3
$11.1K Buy
119
+65
+120% +$7.38K ﹤0.01% 13025
2023
Q2
$7.53K Buy
+54
New +$7.18K ﹤0.01% 13366
2023
Q1
Sell
-33
Closed -$3.52K 14725
2022
Q4
$3.52K Buy
+33
New +$7.18K ﹤0.01% 14202
2022
Q2
Sell
-103
Closed -$36.5K 12898
2022
Q1
$45K Sell
103
-22
-18% -$8.89K ﹤0.01% 12860
2021
Q4
$49K Buy
+125
New +$63.1K ﹤0.01% 13257
2021
Q2
Sell
-123
Closed -$80.9K 13676
2021
Q1
$77K Sell
123
-3
-2% -$2.17K ﹤0.01% 12665
2020
Q4
$80K Buy
+126
New +$79.8K ﹤0.01% 10340
2020
Q3
Sell
-10
Closed -$13K 10074
2020
Q2
$13K Buy
+10
New +$11.8K ﹤0.01% 9609
2020
Q1
Sell
-12
Closed -$8K 9586
2019
Q4
$8K Sell
12
-35
-74% -$28.5K ﹤0.01% 9012
2019
Q3
$42K Buy
+47
New +$64.3K ﹤0.01% 8750
2019
Q2
Sell
-14
Closed -$29K 9171
2019
Q1
$29K Buy
+14
New +$23.3K ﹤0.01% 9001

Other funds holding BKYI

Ken Griffin's BKYI Position: Q1 2026 in Review

Ken Griffin sold out of BIO-key International (BKYI) in Q1 2026, closing a stake of 3,164 shares — an estimated $17.1K sold.

Ken Griffin first reported a position in BKYI in Q1 2019 and held it in 14 quarters. The position peaked at $80K in Q4 2020. 10 funds tracked by Wall St. Rank hold BKYI as of Q1 2026.

  • Ken Griffin reported no remaining BIO-key International position as of Q1 2026 after selling out during the quarter.
  • Ken Griffin sold 3,164 BIO-key International shares in Q1 2026, an estimated $17.1K.
  • Ken Griffin first reported a position in BIO-key International in Q1 2019 and held it in 14 quarters.
  • Ken Griffin's BIO-key International position peaked at $80K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held BIO-key International as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.